Superantigen-induced proliferation of human CD4+CD25- T cells is followed by a switch to a functional regulatory phenotype

Journal of Immunology

Volumn 185, Issue 11, 2010, Pages 6591-6598

  Taylor, Amanda L ^a   Llewelyn, Martin J ^a  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 7 RECEPTOR; STAPHYLOCOCCAL EXOTOXIN A; STREPTOCOCCAL PYROGENIC EXOTOXIN A; STREPTOCOCCAL PYROGENIC EXOTOXIN K; STREPTOCOCCAL PYROGENIC EXOTOXIN L; SUPERANTIGEN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIGEN EXPRESSION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL PROLIFERATION; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLAMMATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGENS, BACTERIAL; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPHENOTYPING; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; SUPERANTIGENS; T-LYMPHOCYTES, REGULATORY;

EID: 78650667875     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002416     Document Type: Article

References (35)

1. Fraser, J. D., and T. Proft. 2008. The bacterial superantigen and superantigen-like proteins. Immunol. Rev. 225:226-243.
2. Swaminathan, S., W. Furey, J. Pletcher, and M. Sax. 1992. Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature 359:801-806.
3. Kappler, J., B. Kotzin, L. Herron, E. W. Gelfand, R. D. Bigler, A. Boylston, S. Carrel, D. N. Posnett, Y. Choi, and P. Marrack. 1989. V beta-specific stimulation of human T cells by staphylococcal toxins. Science 244:811-813.
4. Petersson, K., H. Pettersson, N. J. Skartved, B. Walse, and G. Forsberg. 2003. Staphylococcal enterotoxin H induces V alpha-specific expansion of T cells. J. Immunol. 170:4148-4154.
5. Todd, J., M. Fishaut, F. Kapral, and T. Welch. 1978. Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet 2:1116-1118.
6. Choi, Y., J. A. Lafferty, J. R. Clements, J. K. Todd, E. W. Gelfand, J. Kappler, P. Marrack, and B. L. Kotzin. 1990. Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J. Exp. Med. 172:981-984.
7. Holtfreter, S., D. Grumann, M. Schmudde, H. T. Nguyen, P. Eichler B. Strommenger, K. Kopron, J. Kolata, S. Giedrys-Kalemba, I. Steinmetz, et al. 2007. Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates. J. Clin. Microbiol. 45:2669-2680.
8. Commons, R., S. Rogers, T. Gooding, M. Danchin, J. Carapetis, R. Robins-Browne, and N. Curtis. 2008. Superantigen genes in group A streptococcal isolates and their relationship with emm types. J. Med. Microbiol. 57:1238-1246.
9. LeClaire, R. D., and S. Bavari. 2001. Human Abs to bacterial superantigens and their ability to inhibit T-cell activation and lethality. Antimicrob. Agents Chemother. 45:460-463.
10. Basma, H., A. Norrby-Teglund, Y. Guedez, A. McGeer, D. E. Low, O. El-Ahmedy, B. Schwartz, and M. Kotb. 1999. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect. Immun. 67:1871-1877.
11. Llewelyn, M., and J. Cohen. 2002. Superantigens: microbial agents that corrupt immunity. Lancet Infect. Dis. 2:156-162.
12. Ziegler, S. F. 2006. FOXP3: of mice and men. Annu. Rev. Immunol. 24:209-226.
13. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164.
14. Baecher-Allan, C., J. A. Brown, G. J. Freeman, and D. A. Hafler. 2001. CD4+ CD25high regulatory cells in human peripheral blood. J. Immunol. 167:1245-1253.
15. Walker, M. R., D. J. Kasprowicz, V. H. Gersuk, A. Benard, M. Van Landeghen, J. H. Buckner, and S. F. Ziegler. 2003. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25-T cells. J. Clin. Invest. 112:1437-1443.
16. Walker, M. R., B. D. Carson, G. T. Nepom, S. F. Ziegler, and J. H. Buckner. 2005. De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25-cells. Proc. Natl. Acad. Sci. USA 102:4103-4108.
17. Rellahan, B. L., L. A. Jones, A. M. Kruisbeek, A. M. Fry, and L. A. Matis. 1990. In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B. J. Exp. Med. 172:1091-1100.
18. Kawabe, Y., and A. Ochi. 1990. Selective anergy of V beta 8+, CD4+ T cells in Staphylococcus enterotoxin B-primed mice. J. Exp. Med. 172:1065-1070.
19. Gaus, H., T. Miethke, H. Wagner, and K. Heeg. 1994. Superantigen-induced anergy of V beta 8+ CD4+ T cells induces functional but non-proliferative T cells in vivo. Immunology 83:333-340.
20. Sakaguchi, S., M. Miyara, C. M. Costantino, and D. A. Hafler. 2010. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 10:490-500.
21. Proft, T., P. D. Webb, V. Handley, and J. D. Fraser. 2003. Two novel superantigens found in both group A and group C Streptococcus. Infect. Immun. 71:1361-1369.
22. Allan, S. E., S. Q. Crome, N. K. Crellin, L. Passerini, T. S. Steiner, R. Bacchetta, M. G. Roncarolo, and M. K. Levings. 2007. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19:345-354.
23. Apostolou, I., and H. von Boehmer. 2004. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199:1401-1408.
24. Gavin, M. A., T. R. Torgerson, E. Houston, P. DeRoos, W. Y. Ho, A. Stray-Pedersen, E. L. Ocheltree, P. D. Greenberg, H. D. Ochs, and A. Y. Rudensky. 2006. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. USA 103:6659-6664.
25. Beres, S. B., G. L. Sylva, K. D. Barbian, B. Lei, J. S. Hoff, N. D. Mammarella, M. Y. Liu, J. C. Smoot, S. F. Porcella, L. D. Parkins, et al. 2002. Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc. Natl. Acad. Sci. USA 99:10078-10083.
26. Ikebe, T., A. Wada, Y. Inagaki, K. Sugama, R. Suzuki, D. Tanaka, A. Tamaru, Y. Fujinaga, Y. Abe, Y. Shimizu, H. Watanabe; Working Group for Group A Streptococcus in Japan. 2002. Dissemination of the phage-associated novel superantigen gene speL in recent invasive and noninvasive Streptococcus pyogenes M3/T3 isolates in Japan. Infect. Immun. 70:3227-3233.
27. Maripuu, L., A. Eriksson, and M. Norgren. 2008. Superantigen gene profile diversity among clinical group A streptococcal isolates. FEMS Immunol. Med. Microbiol. 54:236-244.
28. Xu, D., M. Komai-Koma, and F. Y. Liew. 2005. Expression and function of Tolllike receptor on T cells. Cell. Immunol. 233:85-89.
29. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683-765.
30. Sriskandan, S., D. Moyes, and J. Cohen. 1996. Detection of circulating bacterial superantigen and lymphotoxin-alpha in patients with streptococcal toxic-shock syndrome. Lancet 348:1315-1316.
31. Ou, L. S., E. Goleva, C. Hall, and D. Y. Leung. 2004. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J. Allergy Clin. Immunol. 113:756-763.
32. Venet, F., C. S. Chung, H. Kherouf, A. Geeraert, C. Malcus, F. Poitevin, J. Bohé, A. Lepape, A. Ayala, and G. Monneret. 2009. Increased circulating regulatory T cells (CD4 (+) CD25 (+) CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med. 35:678-686.
33. Monneret, G., A. L. Debard, F. Venet, J. Bohe, O. Hequet, J. Bienvenu, and A. Lepape. 2003. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit. Care Med. 31:2068-2071.
34. Venet, F., A. Pachot, A. L. Debard, J. Bohé, J. Bienvenu, A. Lepape, and G. Monneret. 2004. Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25-lymphocytes. Crit. Care Med. 32:2329-2331.
35. Hotchkiss, R. S., C. M. Coopersmith, J. E. McDunn, and T. A. Ferguson. 2009. The sepsis seesaw: tilting toward immunosuppression. Nat. Med. 15:496-497.